Image source: Getty Images.
Continue Reading Below
Healthcare REIT HCP, Inc. (NYSE: HCP) has had an interesting 2016 so far, to say the least. After reporting a surprising loss for the fourth quarter of 2015, shares briefly plunged to levels not seen since 2010, and have since rebounded -- and actually hit a new 2016 high as I'm writing this. Even though the stock has made back all of its losses and then some, there's still a lot of upside potential. With that in mind, here are three things that could easily catapult HCP higher.
The upcoming spinoff is a success
The most-significant news out of HCP this year has been the pending spinoff of its troubled HCR ManorCare assets into a newly created REIT, set to be completed in the second half of the year. So the first potential positive catalyst to keep in mind is if the spinoff accomplishes its intended objectives.
According to HCP's management, the spinoff will:
- Leave HCP's remaining assets as a much-stronger portfolio in terms of asset quality, which translates to better credit quality, and therefore more financial flexibility.
- Create a better environment in which to maximize the value of the HCP ManorCare assets, as the spinoff will allow management to pursue strategies that were either unavailable, or impractical, while the assets were a part of HCP.
- Allow for the creation of two highly specialized management teams, each with a narrow focus.
Continue Reading Below
In the months and years after the spinoff, if it appears that these goals are coming to fruition, it could easily push HCP's share price higher. For example, if HCP starts getting more-favorable financing terms for acquisitions, it could boost growth and profitability. If you're interested, here's a thorough discussion of why the company has chosen to spin off its HCR ManorCare portfolio, and what it expects to achieve by doing so.
Interest rates stay low
This one would actually be a positive catalyst for REITs, in general, and is the primary reason for the incredible performance of REITs such as HCP and rival Welltowerduring the past few months.
Low interest rates help REITs in a couple of ways. Most obviously, they make borrowing money cheaper. Since most REITs rely at least somewhat on borrowed money to finance development and acquisitions, cheaper borrowing usually translates to higher initial profit margins.
In addition, low interest rates make REITs, and specifically their above-average dividends, seem like more-attractive investments. With the 10-year U.S. Treasury paying just 1.5% per year, and many investment-grade bonds not paying much more than that, REIT dividends in the 4% to 7% range seem highly attractive and well worth the risk of owning the stocks. Therefore, more investors buy REIT stocks, creating upside pressure on the share prices.
Data by YCharts.
On the other hand, if investors can get comparable yields from less-risky bonds, it can entice people to sell their REIT holdings in favor of "safer" investments.
The bottom line is that if the current low-interest environment lingers for longer than people expect, it can be a strong positive catalyst for REITs.
Dividend growth continues in 2017
I don't think anyone would argue against the statement that HCP has been a dividend rock star. A member of the S&P Dividend Aristocrats index, HCP has increased its dividend for 31 consecutive years and currently yields over 5.8%.
Image source: HCP investor presentation.
However, the upcoming spinoff creates some uncertainty here. During the first-quarter earnings conference call, HCP's management confirmed that the dividend policy of the newly created "SpinCo" will be set by that company's board. And, while the statements about the pro forma HCP's dividend were intentionally vague, it was mentioned that dividend growth is a consideration of management.
If after the spinoff, the combined dividends of the two REITs exceed HCP's 2016 dividend -- a $2.30 annual payout -- the streak of dividend growth will be alive for shareholders and could help shareholders breathe a sigh of relief and could be a positive catalyst for shares.
Is HCP still a good buy?
HCP has risen by about 50% since its February lows, so it's obviously not as much of a bargain as it was then. Even so, there is plenty of upside potential from here, and as I recently wrote in another article, it's still attractively valued compared to peers. And, while there are certain to be some growing pains once the spinoff happens, I believe that investors who have the time and patience to ride out any short-term volatility will be handsomely rewarded.
A secret billion-dollar stock opportunity
The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here.
Matthew Frankel owns shares of HCP. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.